Chemicals · Founded 1984 · www.zinema.co.in · BSE 538579 · · ISIN INE641Q01019
No Notes Added Yet
Business
Zinema Media & Entertainment Ltd. operates in the Chemicals sector in India. Despite its name, the company's core business involves the manufacturing, processing, and distribution of various chemical products. It likely serves a range of end-user industries such as agriculture, pharmaceuticals, textiles, construction, automotive, or consumer goods. The business model typically involves sourcing raw materials, applying chemical processes to create finished products, and selling them to industrial clients or through distribution channels. Revenue is generated from the sales of these chemical products.
Revenue Mix
Information on specific business segments or their revenue contribution is not provided. Without this data, it is not possible to break down major segments. A typical chemicals company might segment by product type (e.g., specialty chemicals, bulk chemicals, agrochemicals), end-user industry, or geographical region.
Industry
The Indian chemicals industry is diverse and highly fragmented, encompassing bulk chemicals, specialty chemicals, petrochemicals, agrochemicals, and pharmaceuticals. It is a fundamental input provider for numerous other industries. Competition is robust, driven by both domestic players and international imports. Factors like raw material availability, manufacturing process efficiency, R&D capabilities, and regulatory compliance are crucial. Zinema Media & Entertainment Ltd. would position itself within this competitive landscape, potentially by focusing on cost leadership for bulk chemicals, product innovation and customization for specialty chemicals, or developing strong supply chain relationships. Its specific positioning relative to peers (e.g., market leader, niche player, new entrant) is not available.
MOAT
Without specific details about Zinema Media & Entertainment Ltd.'s operations, potential competitive advantages in the chemicals industry could include:
Cost Leadership: Achieving economies of scale or superior process efficiency to produce chemicals at lower costs.
Proprietary Formulations/R&D: Developing unique chemical compounds or advanced manufacturing processes.
Backward Integration: Controlling the supply of critical raw materials to ensure stability and cost efficiency.
Regulatory Expertise: Navigating complex environmental and safety regulations more effectively than competitors.
Customer Relationships & Switching Costs: Building strong, long-term relationships with key industrial clients where switching suppliers can be complex or costly.
Niche Market Focus: Dominating specific, smaller segments with specialized products.
Growth Drivers
Key factors that can drive growth for Zinema Media & Entertainment Ltd. over the next 3-5 years include:
Industrial Growth in India: Expansion in end-user industries like manufacturing, infrastructure, and automotive will directly increase demand for chemicals.
Import Substitution: Government initiatives and domestic manufacturing thrust (e.g., "Make in India") can boost local chemical production.
R&D and Product Innovation: Developing new, high-value-added specialty chemicals or more efficient processes.
Agricultural Sector Demand: Growth in agriculture drives demand for fertilizers, pesticides, and other agrochemicals.
Global Supply Chain Realignment: India's growing role as an alternative manufacturing hub can attract global demand for chemicals.
Risks
Raw Material Price Volatility: Fluctuations in the cost of crude oil, natural gas, and other commodity inputs can significantly impact profitability.
Environmental & Regulatory Risks: Strict and evolving environmental, health, and safety regulations can lead to increased compliance costs, operational restrictions, or penalties.
Intense Competition: The fragmented nature of the industry and presence of large global players can lead to price wars and margin pressure.
Economic Downturns: A slowdown in industrial activity or general economic recession can reduce demand for chemical products.
Technological Obsolescence: Rapid advancements in chemical processes or new product development by competitors could render existing products or methods less competitive.
Supply Chain Disruptions: Geopolitical events, natural disasters, or logistics challenges can disrupt raw material sourcing or product distribution.
Management & Ownership
Information regarding the company's promoters, the quality of its management team, or its specific ownership structure is not provided.
Outlook
Zinema Media & Entertainment Ltd., as a participant in the Indian Chemicals sector, stands to benefit from India's broad industrialization and economic growth, which fuels demand across various chemical segments. The government's focus on domestic manufacturing and infrastructure development also presents favorable tailwinds. However, the company operates in a highly competitive and capital-intensive industry susceptible to volatile raw material prices, stringent environmental regulations, and global economic fluctuations. Its ability to navigate these challenges, coupled with potential for product innovation, cost efficiency, or strategic market positioning, will be crucial for sustained performance.
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 2 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 1 | 0 | 0 | 2 | 9 | 1 | 0 | 0 | 0 | 0 | 1 | |
| Total Expenditure | 0 | 0 | 0 | 3 | 10 | 2 | 0 | 0 | 0 | 0 | 0 | |
| Operating Profit | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | |
| Provision for Tax | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Tax | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | |
| Adjusted Earnings Per Share | 0 | 0 | -0 | -0.4 | -0.3 | -0.6 | -0.1 | -0.3 | -0.2 | 0.4 | 0.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | -100% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 8% | -18% | 24% | 11% |
| ROE Average | 3% | 2% | 0% | -1% |
| ROCE Average | 3% | 2% | 0% | -1% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 1 | 1 |
| Total Current Liabilities | 0 | 0 | 0 | 2 | 2 | 0 | 1 | 1 | 1 | 0 | 0 |
| Total Liabilities | 10 | 10 | 10 | 11 | 11 | 9 | 10 | 9 | 9 | 10 | 10 |
| Fixed Assets | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Total Current Assets | 6 | 6 | 6 | 8 | 8 | 6 | 7 | 7 | 7 | 7 | 8 |
| Total Assets | 10 | 10 | 10 | 11 | 11 | 9 | 10 | 9 | 9 | 10 | 10 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -6 | 1 | -0 | 1 | -1 | -0 | 5 | -0 | 0 | -0 | -0 |
| Cash Flow from Investing Activities | 1 | -0 | 0 | -1 | 1 | 0 | -4 | 0 | 0 | 0 | 1 |
| Cash Flow from Financing Activities | 4 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Net Cash Inflow / Outflow | -0 | 0 | -0 | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.05 | 0.04 | -0 | -0.36 | -0.32 | -0.65 | -0.07 | -0.33 | -0.17 | 0.39 | 0.41 |
| CEPS(Rs) | 0.12 | 0.04 | -0 | -0.36 | -0.32 | -0.65 | -0.07 | -0.33 | -0.17 | 0.39 | 0.41 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 |
| Book NAV/Share(Rs) | 12.18 | 12.29 | 12.36 | 12.08 | 11.95 | 11.56 | 11.75 | 11.8 | 11.89 | 12.28 | 12.69 |
| Core EBITDA Margin(%) | -87.25 | -6748.98 | 0 | -23.22 | -7.27 | -88.22 | 0 | 0 | 0 | 0 | 9.96 |
| EBIT Margin(%) | 20.64 | 557.14 | 0 | -11.97 | -2.47 | -41.66 | 0 | 0 | 0 | 0 | 87.81 |
| Pre Tax Margin(%) | 20.18 | 544.9 | 0 | -12.49 | -2.51 | -41.78 | 0 | 0 | 0 | 0 | 87.57 |
| PAT Margin (%) | 13.17 | 532.65 | 0 | -11.7 | -2.51 | -51.67 | 0 | 0 | 0 | 0 | 87.57 |
| Cash Profit Margin (%) | 31.51 | 532.65 | 0 | -11.7 | -2.48 | -51.67 | 0 | 0 | 0 | 0 | 87.65 |
| ROA(%) | 0.45 | 0.26 | -0.03 | -2.41 | -2.03 | -4.58 | -0.49 | -2.45 | -1.26 | 2.9 | 2.88 |
| ROE(%) | 0.52 | 0.3 | -0.03 | -2.92 | -2.65 | -5.52 | -0.56 | -2.81 | -1.4 | 3.23 | 3.28 |
| ROCE(%) | 0.79 | 0.31 | -0.03 | -2.98 | -2.6 | -4.4 | -0.54 | -2.77 | -1.4 | 3.23 | 3.29 |
| Receivable days | 702.19 | 0 | 0 | 75.43 | 59.1 | 884.46 | 0 | 0 | 0 | 0 | 381.47 |
| Inventory Days | 112.56 | 0 | 0 | 163.39 | 0 | 0 | 0 | 0 | 0 | 0 | 109.77 |
| Payable days | 28.3 | 131.82 | 0 | 170.73 | 71.67 | 454.85 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 140.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0.56 | 0 | 0 | 0 | 0 | 0 | 0.47 | 0 | 1.57 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 18.36 | 1429.82 | 0 | 3.23 | 0.77 | 8.13 | 0 | 0 | 0 | 0 | 21.15 |
| EV/Core EBITDA(x) | 47.1 | 256.63 | -2744.03 | -26.98 | -31.66 | -19.52 | -88.26 | -30.19 | -111.5 | 25.59 | 24.06 |
| Net Sales Growth(%) | -71.62 | -98.12 | -100 | 0 | 316.29 | -90.11 | -100 | 0 | 0 | 0 | 0 |
| EBIT Growth(%) | -32.96 | -49.35 | -109.29 | 0 | 14.26 | -67.04 | 87.63 | -410.9 | 49.88 | 335.29 | 5.24 |
| PAT Growth(%) | 90.06 | -24.13 | -110.68 | -9015.45 | 10.84 | -103.83 | 89.93 | -406.25 | 49.91 | 335.18 | 4.96 |
| EPS Growth(%) | 0 | -24.17 | -110.68 | -9014.25 | 10.84 | -103.86 | 89.92 | -406.12 | 49.91 | 335.16 | 4.98 |
| Debt/Equity(x) | 0 | 0.02 | 0 | 0.01 | 0 | 0.02 | 0.02 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 113.19 | 34.84 | 196.6 | 4.28 | 4.32 | 22.48 | 6.39 | 8.98 | 7.65 | 32.79 | 21.69 |
| Quick Ratio(x) | 111.78 | 34.84 | 196.6 | 3.75 | 4.32 | 22.48 | 6.39 | 8.98 | 7.65 | 32.79 | 21.41 |
| Interest Cover(x) | 44.92 | 45.5 | -10.03 | -23.3 | -61.41 | -356.98 | -97.98 | -977.81 | -2436.17 | 0 | 371.94 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | — | -100% | — |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | +8% | -18% | +24% | +11% |
| ROE Average | +3% | +2% | 0% | -1% |
| ROCE Average | +3% | +2% | 0% | -1% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 | 20.87 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 | 79.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.